News
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 celllines to develop and manufacture AAV ...
Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies Complements and further expands ReciBioPharm's AAV offering Achieves industry ...
LAUSANNE, Switzerland and BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a technology innovation company enabling efficient, cost-effective, and scalable production of viral vectors for ...
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapies; Complements and further expands ReciBioPharm’s AAV offerin ...
Swiss biotechnology company NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide ...
In this webinar, Nathan Sepulveda will share how to specifically and reproducibly measure residual HEK293 DNA during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results